Catalyst4, Inc.
SEC CIK 1900201 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | 10% | 25.31M | $157.89M | — | 4 | 2025-10-28 | 2026-08-14 |
Most active insiders at MPLT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalyst4, Inc. | 10% | $157.89M | — |
| 2 | Novo Holdings A/S | 10% | $16.20M | — |
| 3 | Kroeger Christopher A. | CEO, Dir | — | $12.54M |
| 4 | GILLIS JONATHAN | CAO, Interim CFO | — | $3.56M |
| 5 | Foff Erin Pennock | Chief Medical Off | — | $3.38M |
| 6 | Kreitzer Anatol | Chief Discovery Off | — | $2.78M |
| 7 | Lillie James Woodruff | CSO | — | $2.56M |
| 8 | Hanson Kristopher | GC | — | $1.66M |
| 9 | Malenka Robert C. | Dir | — | $1.60M |
| 10 | Setia Vishwas | CFO | — | $1.10M |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-08-18 18:55 | 2026-08-14 | MPLT | MapLight Therapeutics, Inc. | Catalyst4, Inc. | 10% | P - Purchase | $11.38 | +4.40M | 25.31M | +21% | +$50.07M |
| MI | 2026-07-30 18:39 | 2026-07-28+ | MPLT | MapLight Therapeutics, Inc. | Catalyst4, Inc. | 10% | P - Purchase | $12.66 | +1.21M | 20.91M | +6% | +$15.31M |
| DI | 2025-10-29 | 2025-10-28 | MPLT | MapLight Therapeutics, Inc. | Catalyst4, Inc. | 10% | P - Purchase | $17.00 | +5.44M | 19.70M | +38% | +$92.50M |
| DI | 2025-10-29 | 2025-10-28 | MPLT | MapLight Therapeutics, Inc. | Catalyst4, Inc. | 10% | C - Cnv Deriv | — | +14.26M | 14.26M | New | — |
Purchase Sale Sale after option exercise All abbreviations